bioRxiv Science⌕ Search

bioRxiv · 10.1101/2025.08.21.671547

A meta-analysis of 3-nitrooxypropanol effects on methane production and yield in beef cattle

Abstract

Beef cattle are a major source of enteric methane (CH4) emissions, a potent greenhouse gas (GHG). The feed additive 3-nitrooxypropanol (3-NOP) has been shown to reduce CH4 emissions by inhibiting methyl-coenzyme M reductase, an enzyme critical to methanogenesis in archaea. This study aimed to quantify the effects of 3-NOP on CH4 production (g/d) and yield (g/kg DM intake; DMI) in beef cattle and to evaluate how diet composition influences the mitigation response. A systematic literature review identified 17 peer-reviewed in vivo studies, yielding 45 treatment means. Treatment effects were expressed as absolute and relative mean differences versus control groups. Predictor variables included 3-NOP dose, 3-NOP dose2, DMI, dietary concentration of NDF, CP, starch, fat, and organic matter (OM), roughage proportion, BW, and dietary inclusion of monensin (yes/no). Four types of models were developed, all including the intercept and 3-NOP dose as fixed predictors, differing as follows: (model 1) optional inclusion of 3-NOP dose2 when P < 0.10; (model 2) model 1 plus pre-inclusion of NDF concentration; (model 3) pre-inclusion of NDF concentration plus additional predictors (pairwise r [&le;] 0.5) that significantly improved model accuracy (P < 0.10); and (model 4) additional predictors selected under the same criteria as model 3, without pre-inclusion of NDF concentration. For models 3 and 4, a maximum of 5 predictors were considered and evaluated using leave-one-out cross-validation. Across studies, 3-NOP doses ranged from 32 to 338 mg/kg of DM. On average, 3-NOP reduced CH4 production by 49.9 {+/-} 28.61 g/d (36.2 {+/-} 24.42%) and CH4 yield by 5.3 {+/-} 3.61 g/kg DMI (33.2 {+/-} 25.54%). The best models were selected based on biological interpretability, statistical significance, and predictive accuracy (as measured by RMSE) and included 3-NOP dose, dietary NDF concentration, DMI, and BW as significant predictors (the latter two only for absolute CH4 production). Mitigation efficacy increased with higher DMI and declined with increasing NDF concentration and BW. Absolute reductions of 53.1 g/d and 5.88 g/kg of DMI, and relative reductions of 37.6% in CH4 production and 35.0% in CH4 yield were predicted when moderators were at their mean value (3-NOP dose = 134.4 mg/kg of DM; NDF concentration = 32.8% of DM; DMI of 8.6 kg/d). These results support the effectiveness of 3-NOP in mitigating enteric CH4 emission in beef cattle and provide quantitative models to be used in assessment tools and GHG inventory methodology. ImplicationsThe feed additive 3-nitrooxypropanol effectively reduces enteric methane emissions in beef cattle. This meta-analysis found average reductions of 36.2% in methane production and 33.2% in methane yield. Efficacy depended on diet composition; declining with increasing NDF concentration for both methane production (g/d) and yield (g/kg of DM intake; DMI). Greater DMI increased absolute methane production reduction but did not influence absolute methane yield reduction or relative reduction of both methane production and yield. These results support the targeted use of 3-nitrooxypropanol as a mitigation strategy and provide empirical models to inform greenhouse gas inventories and carbon accounting.

Source connections

Explore related subjects

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

de Oliveira, M. H., Zihlmann, R., Bannink, A., Beauchemin, K., Dijkstra, J., Pressman, E. M., van Gastelen, S., Kebreab, E.. 2025-08-25. A meta-analysis of 3-nitrooxypropanol effects on methane production and yield in beef cattle. https://doi.org/10.1101/2025.08.21.671547

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related preprints

INFORME: coupling information-theoretic experimental design with nonlinear mixed-effects modeling for efficient observation scheduling

Mathematical models of treatment response can inform individualized therapy, but their calibration often requires longitudinal measurements that are costly, burdensome, and collected on fixed schedules. Such schedules may be inefficient, over-sampling patients whose response is already well characterized while delaying informative measurements for those whose model parameters remain uncertain. We present INFORME (INFORmation-theoretic design with Mixed Effects), a framework that combines Bayesian information-theoretic experimental design with nonlinear mixed-effects modeling to adaptively select each patients next measurement time. Population and response-subgroup parameter distributions learned from an existing cohort provide informative priors, allowing candidate measurement times to be ranked by their expected reduction in patient-specific parameter uncertainty. As observations accumulate, priors can be updated to reflect the response subgroup most consistent with the patients data. We evaluate INFORME in two radiotherapy datasets: 150 synthetic tumor volume trajectories from a hybrid cellular automaton model of prostate cancer spheroids (HD1) and longitudinal tumor volumes from 39 patients with head-and-neck cancer (HD2). In HD1, population priors allowed omission of both pretreatment scans, while adaptive scheduling reduced the protocol from nine scans to three or four, with the response group identified from a single post-treatment scan on day 27. In HD2, the adaptive schedule used three scans instead of six and improved prediction by delaying the first on-treatment scan from week 1 to week 2, avoiding transient dynamics that produced false-positive and false-negative response projections. Across both datasets, the adaptive schedules used a mean of 2.7 scans in stead of seven and advanced completion of the patient-specific prediction by a mean of 15.5 days (95% CI, 6.7-24.3) relative to the equidistant protocol, while treatment duration remained unchanged. INFORME therefore reduces measurement burden and accelerates patient-specific prediction by concentrating observations at times that are most informative for model calibration.

systems biology↗

Sobetirome, a thyroid hormone receptor beta agonist, is a potential therapeutic agent for pulmonary fibrosis

Idiopathic pulmonary fibrosis (IPF) is a progressive and fatal disease with limited treatment options. Our group previously identified the antifibrotic potential of thyroid hormone, triiodothyronine (T3); however, clinical translation of thyroid hormone therapy is limited by its systemic adverse effects. In this study, we investigate whether sobetirome, a selective and well tolerated thyroid hormone receptor beta (THRB) agonist, offers antifibrotic benefits of thyroid hormone while minimizing systemic toxicity. Our study reveals that sobetirome, administered via intraperitoneal or inhalational routes, effectively mitigates bleomycin-induced pulmonary fibrosis in mice, with no evidence of toxicity. We identified that sobetirome restores mitochondrial homeostasis via activating the THRB-PPARGC1a axis. This protects alveolar type II epithelial cells from injury-induced apoptosis while selectively inducing apoptosis and metabolic reprogramming in apoptosis resistant IPF fibroblasts. Cell-specific deletion of Ppargc1a in either alveolar epithelial cells or fibroblasts abolishes sobetirome-mediated protection, establishing PPARGC1a as an essential mediator of therapeutic response. Importantly, sobetirome reverses fibrosis-associated transcriptional programs in human IPF lung tissue, reducing expression of key fibrosis-associated genes, including collagen I alpha 1 (COL1A1), collagen III alpha 1 (COL3A1), periostin (POSTN), cathepsin K (CTSK), and Chitinase 3 Like 1 (CHI3L1), while promoting extracellular matrix remodeling, epithelial restoration, and tissue homeostasis. Collectively, our findings identify THRB activation as a novel metabolic strategy for reversing pulmonary fibrosis. Across complementary in vitro, in vivo, and human ex vivo models, sobetirome restores mitochondrial function, modulates apoptotic pathways in pathogenic cells, and promotes fibrosis resolution, highlighting its potential as a lung-targeted therapeutic approach for IPF and other fibrotic lung diseases.

systems biology↗

Mechanistic modeling of bacterial translation initiation across growth conditions

Translation frequency in bacteria depends on how ribosomes, mRNAs, and initiation factors are allocated across growth conditions. Here, we developed a mechanistic ODE-based model of Escherichia coli translation that represents initiation, elongation, termination, and coupled auxiliary processes. Growth-dependent abundances were derived from physiological relationships and reprocessed omics data, and simulated outputs were compared with translation-frequency and active-ribosome references. The model predicts a continuous shift from complex-formation-limited toward ribosome-limited behavior as growth increases. This shift is characterized by a decline in free-ribosome abundance, whereas initiation-factor pools remain largely unbound and do not become depleted in parallel. Together with the implemented IF-dependent kinetic term, this preserved availability provides a model-internal route through which productive initiation can be maintained despite increasing ribosome utilization. Consistently, transcript-wide ribosome loading remains below its theoretical maximum, while COG-level simulations reveal distinct sector-specific translation-frequency trajectories. The study therefore provides a resource-allocation framework for interpreting how mRNA--ribosome interactions shape bacterial translation across growth conditions.

systems biology↗